Effect of Nebivolol Compared With Metoprolol in Hypertensive Patients With Peripheral Arterial Disease

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2011
This is a 26-week, prospective double-blind, randomized pilot trial of nebivolol versus an active control, metoprolol succinate, in patients with established lower-extremity peripheral artery disease, hypertension, and at least moderate risk for coronary artery disease.
Epistemonikos ID: 224c66d61882191fed3843655913adadd6adcd80
First added on: May 10, 2024